Research and Markets: Cambodia Pharmaceutical and Healthcare Report Q2 2011

[BUSINESS WIRE]

DUBLIN--Research and Markets has announced the addition of the "Cambodia Pharmaceutical and Healthcare Report Q2 2011" report to their offering.

The Cambodia Pharmaceuticals & Healthcare Report features Business Monitor International (BMI)'s 5 and 10-year forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

Cambodia Pharmaceuticals & Healthcare Report provides industry professionals, market investors and corporate and financial services analysts with independent forecasts and competitive intelligence on the Cambodian pharmaceutical and healthcare industry.

Key Benefits:

• Benchmark independent 5 and 10-year pharmaceutical and healthcare industry forecasts on Cambodia to test other views - a key input for successful budgeting and strategic business planning in the Cambodian pharmaceutical and healthcare market.
• Target business opportunities and risks in the Cambodian pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in Cambodia.
• Assess the activities, strategy and market position of your competitors, partners and clients via Company Profiles (inc. SWOTs, KPIs, latest activity) and Competitive Landscape Tables. 

Coverage Includes:

• Executive Summary & Industry SWOT: An at-a-glance perspective on latest regulatory developments, key forecast indicators and major corporate developments, covering the prescription, OTC and generics markets. The SWOT outlines strategic factors which affect BMI's forecast analysis, and taken together with BMI's political, economic and business environment SWOTS, give a complete overview of market climate.
• Market Summary: Snapshot of key market characteristics, including total size of pharmaceuticals and healthcare segments, growth drivers, leading therapeutic areas and the competitive landscape.
• Regulatory Regime: Details of the industry regulatory framework and key legislation covering the licensing of new products/services, pricing and reimbursements, intellectual property, taxation, advertising, as well as an analysis of the overall regulatory burden.
• Industry Developments: Focus on government healthcare reforms, epidemiological trends, company M&As, product launches, market entries, FDI activity, R&D, biotechnology, clinical trials and supply chain issues.
• Macroeconomic Forecasts: Nominal and real GDP, % real GDP growth, % private consumption growth, % industrial output growth, % consumer price index, % GDP price deflator, exports, imports, trade balance, current account balance, foreign direct investment, exchange rate against US$, government expenditure, external debt.

Companies Mentioned:

• PharmaProduct Manufacturing
• Cambodia Pharmaceutical Enterprises
• Multinational Companies
• Sanofi-Aventis
• Pfizer

For more information visit http://www.researchandmarkets.com/research/7e72ea/cambodia_pharmaceu.